logo

For the Inventor, By the Inventor

Vimercate, Italy

Stefania Gagliardi

This inventor holds 15 USPTO granted patents and 5 published patent applications and 7 EPO patents. Top assignees: Polichem S.a., Nikem Research S.r.l., Neurotune Ag. Active years: 1999-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefania Gagliardi. Retrieved from https://idiyas.com/inventor/stefania-gagliardi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 20.0

 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 43(Granted Patents)


Location History:

  • Como, IT (2000 - 2003)
  • Milan, IT (1999 - 2005)
  • Baranzate di Bollate, IT (2007 - 2008)
  • Vimercate, IT (2009 - 2016)

Company Filing History:

goldMedal5 out of 29 
 
Polichem S.a.
 patents
silverMedal3 out of 3 
 
Nikem Research S.r.l.
 patents
bronzeMedal2 out of 9 
 
Neurotune Ag
 patents
4. 2 out of 2,198 
 
Smithkline Beecham Corporation
 patents
5. 1 out of 6 
 
Dac S.r.l.
 patents
6. 1 out of 40 
 
Newron Pharmaceuticals S.p.a.
 patents
7. 1 out of 6 
 
Smithkline Beecham Farmaceutici
 patents
8. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2016

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9284306 - (R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel (2016-03-15),
2. 9067927 - (R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel (2015-06-30),
3. 8969380 - Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents (2015-03-03),
4. 8729098 - Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof (2014-05-20),
5. 8729076 - Secondary 8-hydroxyquinoline-7-carboxamide derivatives (2014-05-20),
6. 8242175 - Class of histone deacetylase inhibitors (2012-08-14),
7. 7732473 - Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof (2010-06-08),
8. 7544705 - Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents (2009-06-09),
9. 7411091 - N-acyl-N'-benzyl-alkylendiamino derivatives (2008-08-12),
10. 7220769 - Azolylbenzamides and analogues and their use for treating osteoporosis (2007-05-22),
11. 6903117 - Indole derivatives for the treatment of osteoporosis (2005-06-07),
12. 6787550 - Indole derivatives and their use for the treatment of osteoporosis amongst other applications (2004-09-07),
13. 6506758 - Indole derivatives useful A.O. for the treatment of osteoporosis (2003-01-14),
14. 6025390 - Heteroaromatic pentadienoic acid derivatives useful as inhibitors of (2000-02-15),
15. 5981525 - Indole derivatives useful in the treatment of osteoporosis (1999-11-09),

Title: Celebrating the Innovative Contributions of Stefania Gagliardi

Introduction: Stefania Gagliardi, an accomplished inventor based in Vimercate, Italy, has made significant strides in the field of pharmaceutical innovations. With a remarkable portfolio of 15 patents, her work primarily focuses on the development of novel antimicrobial agents.

Latest Patents: Among her latest innovations is the patent for (R)-Nifuratel, a compound noted for its efficacy in treating infections. This invention emphasizes the use of (R)-Nifuratel as both a bactericide and bacteriostatic agent, highlighting its superior antimicrobial profile compared to the conventional nifuratel racemate or (S)-nifuratel. In addition, Gagliardi has disclosed a new procedure for the synthesis of both (R)-Nifuratel and (S)-Nifuratel, further contributing to the advancement of pharmaceutical science.

Career Highlights: Stefania Gagliardi's career includes invaluable experience at leading companies like Polichem S.A. and Nikem Research S.r.l. Through her roles, she has influenced the development of groundbreaking treatments and contributed to important advancements in antimicrobial research.

Collaborations: Throughout her journey, Gagliardi has collaborated with notable professionals such as Carlo Farina and Federico Mailland, enhancing the breadth and impact of her work in the pharmaceutical industry. These collaborations exemplify the importance of teamwork in the innovation process and the sharing of knowledge among experts in various fields.

Conclusion: Stefania Gagliardi stands as a testament to the impact of dedicated research and innovation in the pharmaceutical sector. Her contributions not only advance medical treatments but also inspire future generations of inventors to pursue groundbreaking discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…